Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Alessandro VitaleGianluca Svegliati-BaroniAlessio OrtolaniMonica CuccoGiulio V Dalla RivaEdoardo Giovanni GianniniPiscaglia FabioGianludovico RapacciniMariella Di MarcoEugenio CaturelliMarco ZoliRodolfo SaccoGiuseppe CabibboFabio MarraAndrea MegaFilomena MoriscoAntonio GasbarriniFrancesco Giuseppe FoschiGabriele MissaleAlberto MasottoGerardo NardoneGiovanni RaimondoFrancesco AzzaroliGianpaolo VidiliFilippo OliveriFilippo PelizzaroRafael Ramirez MoralesUmberto CilloFranco TrevisaniLuca MieleGiulio MarchesiniFabio Farinatinull nullPublished in: Gut (2021)
The prevalence of MAFLD HCC in Italy is rapidly increasing to cover the majority of patients with HCC. Despite a less favourable cancer stage at diagnosis, patients with MAFLD HCC have a lower risk of HCC-related death, suggesting reduced cancer aggressiveness.